23 November 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics evaluated the risk of esophageal cancer after oral bisphosphonates.
Bisphoshonates, which are used in the treatment and prevention of osteoporosis, have recently bee
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors